May & Baker, who have not hitherto marketed an oral diuretic, have now introduced clorexolone (Nefrolan). This drug contains the active radicals present in the thiazides but lacks the benzothiadiazine nucleus. Its pharmacological properties, uses and unwanted actions are those of the thiazides and chlorthalidone. Clorexolone does not significantly inhibit carbonic anhydrase in vivo. Whether, like other oral diuretics, it can cause diabetes mellitus1 is not yet known.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.